Results 221 to 230 of about 19,374,294 (402)

Safety of drug administration from the perspective of hospitalized patients in selected hospitals of the South Bohemia Region

, 2022
Hana Hajduchová, Iva Brabcová, Radka Prokešová, Valérie Tóthová, Ivana Chloubová, Květoslava Slabáková, Dana Velimská, Edita Klavíková, Hana Matějovská Kubešová, Martin Doseděl, Josef Malý   +10 more
openalex   +1 more source

Reconfigurable Nucleic Acid Nanoparticles with Therapeutic RNAi Responses to Intracellular Disease Markers

Advanced Functional Materials, EarlyView.
Many known diseases arise from dysregulated gene expression, and differentially expressed genes can serve as biomarkers to distinguish diseased cells from healthy tissues. In this study, reconfigurable nucleic acid nanoparticles (recNANPs) are introduced that can detect overexpressed cancer biomarkers and subsequently release RNAi inducers to silence ...
Yelixza I. Avila, Anh Ha, Morgan R. Chandler, Nathalia Leal Santos, Taejin Kim, Hannah S. Newton, Marina A. Dobrovolskaia, Kirill A. Afonin   +7 more
wiley   +1 more source

Addendum to “Patient Safety Alert: Serious Harm Associated With Failure to Adjust Clozapine Dosing”

Patient Safety
Patient Safety Authority
doaj   +1 more source

The Value of Patient Safety Learning Laboratories. [PDF]

J Patient Saf
Bates DW.
europepmc   +1 more source

The VertiGO! Trial protocol: A prospective, single-center, patient-blinded study to evaluate efficacy and safety of prolonged daily stimulation with a multichannel vestibulocochlear implant prototype in bilateral vestibulopathy patients

Bernd L. Vermorken, Benjamin Volpe, Stan C J van Boxel, Joost J. A. Stultiens, Marc van Hoof, Rik Marcellis, Elke Loos, Alexander van Soest, Christopher McCrum, Kenneth Meijer, Nils Guinand, Angélica Pérez Fornos, Vincent Van Rompaey, Elke Devocht, Raymond van de Berg   +14 more
openalex   +2 more sources

Use of drug manufacturers’ patient assistance programs by safety net providers [PDF]

, 2002
Katheryne Richardson, Lorne E. Basskin
openalex   +1 more source

FeDSNP‐Pa Nanoassemblies: A Triple‐Action Therapeutic Strategy Targeting Oxidative Stress, Inflammation, and Pyroptosis for Retinal Ganglion Cell Protection in Glaucoma

Advanced Functional Materials, EarlyView.
FeDSNP‐Pa, a metallized nanoparticle loaded with sodium pyruvate (Pa), exerts triple therapeutic effects by scavenging reactive oxygen species (ROS), suppressing inflammatory responses, and inhibiting pyroptosis signaling pathways. This multifunctional neuroprotective strategy protecting retinal ganglion cells (RGCs) from elevated intraocular pressure ...
Yukun Wu, Xue Li, Tong Wu, Dan Ji, Yugang Bai, Xuezhi Zhou   +5 more
wiley   +1 more source

Patient Safety Leaders' Perception of Patient Safety Practices in Eight Asia-Pacific Countries: Survey Based on the Global Patient Safety Action Plan Framework. [PDF]

Risk Manag Healthc Policy
Ahn JY, Sim MWC, Foo ZST, Tan KH.
europepmc   +1 more source

Safety and Efficacy of PDpoetin for Management of Anemia in Patients with End Stage Renal Disease on Maintenance Hemodialysis: Results from a Phase IV Clinical Trial [PDF]

, 2014
Abbas Norouzi‐Javidan, Heshmatollah Shahbazian, Amirhossein Emami, Mir Saeed Yekaninejad, Hassan Emami-Razavi, Masoumeh Farhadkhani, Ahmad Ahmadzadeh, Fazel Gorjipour   +7 more
openalex   +1 more source

Biomaterial Strategies for Targeted Intracellular Delivery to Phagocytes

Advanced Functional Materials, EarlyView.
Phagocytes are essential to a functional immune system, and their behavior defines disease outcomes. Engineered particles offer a strategic opportunity to target phagocytes, harnessing inflammatory modulation in disease. By tuning features like size, shape, and surface, these systems can modulate immune responses and improve targeted treatment for a ...
Kaitlyn E. Woodworth, Neal I. Callaghan, Locke Davenport Huyer   +2 more
wiley   +1 more source